Feasibility study on the retention of superporous hydrogel composite polymer in the intestinal tract of man using scintigraphy

被引:30
作者
Dorkoosh, FA
Stokkel, MPM
Blok, D
Borchard, G
Rafiee-Tehrani, A
Verhoef, JC
Junginger, HE
机构
[1] Leiden Univ, Dept Pharmaceut Technol, Leiden Amsterdam Ctr Drug Res, NL-2300 RA Leiden, Netherlands
[2] Leiden Univ, Ctr Med, Dept Nucl Med, NL-2300 RC Leiden, Netherlands
[3] Leiden Univ, Ctr Med, Leiden Univ Hosp Pharm, NL-2300 RC Leiden, Netherlands
关键词
superporous hydrogels (SPH); SPH composite; scintigraphy; residence time; intestinal tract; man;
D O I
10.1016/j.jconrel.2004.06.012
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
In recent years, many complex oral drug delivery systems have been developed using various polymers in order to achieve better drug targeting and drug absorption in the intestinal tract. Superporous hydrogel (SPH) and SPH composite (SPHC)-based drug delivery systems were also developed for the targeted delivery of peptide drugs into the intestinal tract. In the present study, the retention time of SPHC polymer is studied in man using the scintigraphy technique. To that purpose, SPHC polymers were radiolabelled with Tc-99m and administered orally in an enteric-coated gelatin capsule. The location of the radiolabelled polymer was monitored in five healthy volunteers while the subjects were sitting in front of a large field of view gamma camera. The results showed that enteric-coated gelatin capsules remained in the stomach for 75 to 150 min after oral administration to fasted volunteers and that the SPHC polymers thereafter attached to the upper part of the small intestine for at least 45 to 60 min due to their mechanical fixation properties. No discomfort was observed in any of the volunteers after oral administration of these polymers, which indicates that they are safe to be applied for oral drug delivery systems in man. (C) 2004 Elsevier B.V. All rights reserved.
引用
收藏
页码:199 / 206
页数:8
相关论文
共 20 条
  • [11] Development and characterization of a novel peroral peptide drug delivery system
    Dorkoosh, FA
    Verhoef, JC
    Borchard, G
    Rafiee-Tehrani, M
    Junginger, HE
    [J]. JOURNAL OF CONTROLLED RELEASE, 2001, 71 (03) : 307 - 318
  • [12] Groning R, 1996, EUR J PHARM BIOPHARM, V42, P25
  • [13] HUNTER WW, 1969, J NUCL MED, V10, P607
  • [14] Comparative scintigraphic assessment of the intragastric distribution and residence of cholestyramine, Carbopol 934P and sucralfate
    Jackson, SJ
    Bush, D
    Perkins, AC
    [J]. INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2001, 212 (01) : 55 - 62
  • [15] LEHR CM, 1994, CRIT REV THER DRUG, V11, P119
  • [16] MUCOADHESIVE POLYMERS IN PERORAL PEPTIDE DRUG-DELIVERY .2. CARBOMER AND POLYCARBOPHIL ARE POTENT INHIBITORS OF THE INTESTINAL PROTEOLYTIC-ENZYME TRYPSIN
    LUESSEN, HL
    VERHOEF, JC
    BORCHARD, G
    LEHR, CM
    DEBOER, AG
    JUNGINGER, HE
    [J]. PHARMACEUTICAL RESEARCH, 1995, 12 (09) : 1293 - 1298
  • [17] GASTROINTESTINAL TRANSIT OF A SOLID INDIGESTIBLE CAPSULE AS MEASURED BY RADIOTELEMETRY AND DUAL GAMMA-SCINTIGRAPHY
    MOJAVERIAN, P
    CHAN, K
    DESAI, A
    JOHN, V
    [J]. PHARMACEUTICAL RESEARCH, 1989, 6 (08) : 719 - 724
  • [18] Evaluation of the feasibility and use of a prototype remote drug delivery capsule (RDDC) for non-invasive regional drug absorption studies in the GI tract of man and beagle dog
    Parr, AF
    Sandefer, EP
    Wissel, P
    McCartney, M
    McClain, C
    Ryo, UY
    Digenis, GA
    [J]. PHARMACEUTICAL RESEARCH, 1999, 16 (02) : 266 - 271
  • [19] PHILLIPS SF, 1988, ILLUSTRATED GUIDE GA, P187
  • [20] Scintigraphy of the small intestine: a simplified standard for study of transit with reference to normal values
    Rao, S
    Lele, V
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2002, 29 (07) : 971 - 971